Successful treatment of genital warts with cidofovir cream in a pediatric patient with Fanconi anemia. (July 2020)

• Record Type: Journal Article
• Authors: Muffarrej, Duaa; Khattab, Eman; Najjar, Rula
• Is Part Of: Journal of oncology pharmacy practice. Volume 26:Number 5(2020)
• Page Start: 1234
• Page End: 1236
• Publication Date: 2020-07
• Subjects: Cidofovir -- human papillomavirus -- condylomata acuminata -- Fanconi anemia -- pediatrics; Cancer -- Chemotherapy -- Periodicals; Clinical pharmacology -- Periodicals; 616.994061
• DOI: 10.1177/1078155219886924
• Languages: English
• ISSNs: 1078-1552

Abstract

Introduction: Patients with Fanconi anemia have an increased susceptibility to malignancies associated with human papillomavirus, and thus prevention and early management of human papillomavirus infections in this patient population are crucial. Case report: A nine-year-old girl with Fanconi anemia developed genital warts about three years after undergoing haplo-identical stem cell transplant. The transplant was complicated by chronic graft-versus-host disease, and the patient had therefore received multiple immunosuppressants. The genital warts were treated with several creams, but minimal improvement was reported. Management and outcome: Cidofovir was extemporaneously compounded into an unscented 1% moisturizing cream and applied daily at bedtime to the genital warts. By the end of treatment, the warts had been successfully treated, and no adverse events were reported. The patient is still free of any lesions at six months after completing treatment. Discussion: Although reports have been published on the use of cidofovir cream, most were in adults with non-genital warts. Cidofovir cream may be considered as a treatment option for refractory genital warts in pediatric patients. However, further studies are needed to better define the optimal preparation and dosing for such patient population.